Multichem® ID-HEP 1
Multichem® Infectious Disease (ID) Quality Controls (QC) samples, have been validated to match assays commonly used for infectious diseases testing.
Multichem ID-HEP1 is an unassayed positive control with no platform claims in the USA.
)
Product Description
Multichem ID-HEP1 consolidates three analytes. This unassayed product is validated for specific platforms, including; Abbott Architect and Abbott Alinity i.
INFORMATION FOR USA ONLY: This product is not intended for use in donor screening testing. This is an unassayed product, with no platform claims in the USA.
Benefits
No requirements for sample aliquoting
Direct sampling from control vials
Direct control sample placement and storage on instrument specific carriers
Elimination of QC sample transposition errors
Barcoded for ease of use
Increased compliance with health and safety guidelines
Features
24 month closed tube stability at -10°C to -25°C
60 day open tube stability at 2°C to 8°C
Ready-to-use liquid stable
Consolidates 3 analytes
Targeted as a low-positive control
Representative reactivity provided in the package insert
Third party independent quality control
Analyte List
HBeAg
Anti-HAV IgM
Anti-HBc IgM
Please refer to lot specific package inserts for stability and performance claims.
Ordering
Name
Description
Kit
Part Code
Multichem ID-HEP1
Positive control
4 x 4mL
2000-0106
Name
Multichem ID-HEP1
Description
Positive control
Kit
4 x 4mL
Part Code
2000-0106
Order Multichem ID-HEP1 Today
Electronic Instructions For Use (eIFU)
)
Electronic Instructions For Use (eIFU)
Navigate to our eIFU page to easily access an electronic version the product instructions for use.
Go To eIFU pageFind a product by analyte, instrument, partcode or name
Why Technopath
Technopath was the first company in the world to develop truly consolidated third party quality controls for hospital laboratories.
Through the benefits of test consolidated QC, Technopath’s Multichem® customers have increased their laboratory efficiencies and reduced the cost of their quality control program.
Our Clients
Sign up to our newsletter for the latest updates
Be one of the first to receive news from Technopath Clinical Diagnostics.